News
TargED Biopharmaceuticals and Good Biomarker Sciences receive MIT R&D collaboration grant
We are very pleased to announce that Economic Board Utrecht has granted €213.000 to support a 2-year joint R&D program between TargED Biopharmaceuticals and Good Biomarker Sciences.
UFO Biosciences launches its cell subtyping services
UFO Biosciences is happy to announce the launch of its cell subtyping services. UFO Biosciences offers a unique solution to identify rare cell subtypes in a heterogeneous sample population to drive dedicated R&D.
Levels Diagnostics awarded the MIT R&D grant
Levels Diagnostics was awarded the MIT R&D grant by the Provide of South Holland. Together with Omnigen and SG papertronics the consortium will develop a test that can quickly identify early signs of liver damage in patients.
Cristal Therapeutics and Intravacc announce strategic collaboration to advance novel vaccine platforms
Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug
We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!
This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Summer 2020 is PacingCure!
This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech
BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
Venture Challenge alumni TargED closes seed investment
TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug TargED Biopharmaceuticals, a biotech spin-
Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020
Toxys is very proud to announce that they been selected as one of the FD Gazelles of 2020.